Fig. 4From: Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1Sorafenib enhances DHA’s cytotoxicity in a concentration- and time-dependent manner in MDA-MB-231 cells. Cells were treated with Sorafenib and DHA at different concentrations for 48 h a or for different durations b Cell viability was determined by the MTS assay (n = 3, means ± SEM, *p < 0.01)Back to article page